Clinical trial
Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Uncomplicated Falciparum Malaria in Western Kenya
NCT02411994 is registered in ClinicalTrials.gov with Royal Tropical Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Uncomplicated Falciparum Malaria in Western Kenya
- Lead sponsor
- Royal Tropical Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- August 31, 2017
- Enrollment
- 197 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.